Enter assignee name

Trademarks = 1

Forward Citations = 20

Loading Chart...

7 inventors (with patents filed for the assignee):

Adam Galan (8 out of 12 patents)

Ritu Lal (8 out of 12 patents)

Wendy Luo (7 out of 11 patents)

4. Paul S Shapiro (1 out of 10 patents)

5. Alexander D MacKerell, Jr (1 out of 23 patents)

6. Steven Fletcher (1 out of 13 patents)

7. Chakk Ramesha (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12404259 - Inhibitors of extracellular signal-regulated kinase (2025-09-02),

2. 12331024 - Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors (2025-06-17),

3. 11976049 - Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors (2024-05-07),

4. 11926635 - P38α mitogen-activated protein kinase inhibitors (2024-03-12),

5. 11555020 - Substituted naphthyl p38α mitogen-activated protein kinase inhibitors (2023-01-17),

6. 11440918 - p38α mitogen-activated protein kinase inhibitors (2022-09-13),

7. 11390581 - Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate (2022-07-19),

8. 11286260 - P38α mitogen-activated protein kinase inhibitors (2022-03-29),

Gen1e Lifesciences Inc. is a biotechnology company focused on developing innovative therapies for genetic diseases. Leveraging cutting-edge gene editing technologies, we aim to unlock the potential of genetic medicine to improve the lives of patients worldwide. Our team of experts is dedicated to researching and developing breakthrough treatments that address unmet medical needs in the field of rare genetic disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

8 Patents

#216 in Palo Alto, CA

#8,296 in California

#34,918 in US

Palo Alto, CA, United States of America

Gen1e Lifesciences Inc.